Cargando…

The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study

BACKGROUND: The present study aims to evaluate the cost-effectiveness of the newly introduced varicella and herpes zoster (HZ) vaccination programmes in Italy. The appropriateness of the introduction of the varicella vaccine is highly debated because of concerns about the consequences on HZ epidemio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melegaro, Alessia, Marziano, Valentina, Del Fava, Emanuele, Poletti, Piero, Tirani, Marcello, Rizzo, Caterina, Merler, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048801/ https://www.ncbi.nlm.nih.gov/pubmed/30012132 http://dx.doi.org/10.1186/s12916-018-1094-7

Ejemplares similares

Perspectives on the Impact of Varicella Immunization on Herpes Zoster. A Model-Based Evaluation from Three European Countries
por: Poletti, Piero, et al.
Publicado: (2013)

The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster
por: Marangi, Luigi, et al.
Publicado: (2017)

Parental vaccination to reduce measles immunity gaps in Italy
por: Marziano, Valentina, et al.
Publicado: (2019)

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019)

Herpes Zoster and Varicella
por: Fordyce, A. Dingwall
Publicado: (1919)

Herpes Zoster and Varicella
por: Chatterjee, Bijoy Krishna
Publicado: (1929)

Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020
por: Guzzetta, Giorgio, et al.
Publicado: (2020)

Modeling the Impact of Exogenous Boosting and Universal Varicella Vaccination on the Clinical and Economic Burden of Varicella and Herpes Zoster in a Dynamic Population for England and Wales
por: Sharomi, Oluwaseun, et al.
Publicado: (2022)

Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy
por: Poletti, Piero, et al.
Publicado: (2021)

Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020
por: Poletti, Piero, et al.
Publicado: (2020)

Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy
por: Poletti, Piero, et al.
Publicado: (2021)

Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella
por: Wu, Po-Yuan, et al.
Publicado: (2013)

Modeling the impact of changes in day-care contact patterns on the dynamics of varicella transmission in France between 1991 and 2015
por: Marziano, Valentina, et al.
Publicado: (2018)

The epidemiology of Varicella Zoster Virus infection in Italy
por: Gabutti, Giovanni, et al.
Publicado: (2008)

A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden
por: Zardini, Agnese, et al.
Publicado: (2021)

Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data
por: Forbes, Harriet, et al.
Publicado: (2020)

RELATION OF VARICELLA TO HERPES ZOSTER : I. STATISTICAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Varicella and herpes zoster vaccine development: lessons learned
por: Warren-Gash, Charlotte, et al.
Publicado: (2017)

The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster
por: Min, Seong-Won, et al.
Publicado: (2016)

Tozinameran: Varicella zoster virus meningitis and herpes zoster infections : case report
Publicado: (2022)

Periodicity of varicella-zoster virus in the presence of immune boosting and clinical reinfection with varicella
por: Korostil, Igor A, et al.
Publicado: (2015)

Social Contact Structures and Time Use Patterns in the Manicaland Province of Zimbabwe
por: Melegaro, Alessia, et al.
Publicado: (2017)

Transmission Potential of Chikungunya Virus and Control Measures: The Case of Italy
por: Poletti, Piero, et al.
Publicado: (2011)

RELATION OF VARICELLA TO HERPES ZOSTER : II. CLINICAL AND EXPERIMENTAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Herpes Zoster in an Immunocompetent Child without a History of Varicella
por: Shang, Bing-Shiau, et al.
Publicado: (2021)

Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study
por: Horn, Johannes, et al.
Publicado: (2018)

An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report
por: Xie, Guangcheng, et al.
Publicado: (2020)

The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014
por: Chan, D. Y. W., et al.
Publicado: (2018)

Individual’s daily behaviour and intergenerational mixing in different social contexts of Kenya
por: Del Fava, Emanuele, et al.
Publicado: (2021)

The early phase of the COVID-19 epidemic in Lombardy, Italy
por: Cereda, Danilo, et al.
Publicado: (2021)

Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children
por: Moodley, Amaran, et al.
Publicado: (2019)

Tozinameran: Herpes varicella-zoster virus infection: 2 case reports
Publicado: (2022)

Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
por: Tayyar, Ralph, et al.
Publicado: (2023)

The role of different social contexts in shaping influenza transmission during the 2009 pandemic
por: Ajelli, Marco, et al.
Publicado: (2014)

The introduction of ‘No jab, No school’ policy and the refinement of measles immunisation strategies in high-income countries
por: Trentini, Filippo, et al.
Publicado: (2019)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models
por: Del Fava, Emanuele, et al.
Publicado: (2016)

Trends in Hospitalizations With Primary Varicella and Herpes Zoster During the Prevaricella and Initial Postvaricella and Herpes Zoster Vaccine Eras, Connecticut, 1994–2012
por: Humes, Elizabeth A., et al.
Publicado: (2015)

Herpes Zoster: the rationale for the introduction of vaccination in Italy
por: PAGANINO, C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o7sv9aftjnulubg2mr3ckjve5t